Tax Provision - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.2 PLN -0.18% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Tax Provision Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Tax Provision
-zł23k
CAGR 3-Years
74%
CAGR 5-Years
71%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Tax Provision
-zł899k
CAGR 3-Years
-33%
CAGR 5-Years
-98%
CAGR 10-Years
-21%
M
Medicofarma Biotech SA
WSE:MDB
Tax Provision
zł0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Tax Provision
zł4.2m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Tax Provision?
Tax Provision
-23k PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Tax Provision amounts to -23k PLN.

What is Ryvu Therapeutics SA's Tax Provision growth rate?
Tax Provision CAGR 5Y
71%

Over the last year, the Tax Provision growth was 99%. The average annual Tax Provision growth rates for Ryvu Therapeutics SA have been 74% over the past three years , 71% over the past five years .

Back to Top